Jeffrey Sparks MD MMSc
@jeffsparks
Followers
6K
Following
18K
Media
507
Statuses
8K
Rheumatologist | Associate Professor of Medicine | @BrighamWomens | @harvardmed | Investigating rheumatoid arthritis susceptibility, RA-ILD, and outcomes | ⚡️⚡️
Boston, MA
Joined June 2009
#guidelines everywhere @jeffsparks presents points of interest from #ACR #ILD #recommendations - a joint venture with American College of Chest Physicians While simultaneously the EULAR ILD recommendations are being unveiled! @RheumNow #EULAR2025 @eular_org @ACRheum
0
7
15
Some RA-ILD is less of a worry, some is critical. How do we stratify? Great modelling work from Korea & @jeffsparks - model stratifying really well, even without KL-6. We need to do this more, so we can go really hard early when we need to. #EULAR2025 OP0329 @RheumNow
0
7
22
🗣️ “A one-size-fits-all approach to increase #vaccine uptake may have had some unintended consequences,” @jeffsparks @harvardmed @BrighamWomens
#COVID_19 💉🥼 Feature @HealioRheum ⬇️ https://t.co/XN8nSu68bF
healio.com
Inconsistent messaging and evolving recommendations surrounding COVID-19 vaccination protocols may have contributed to both hesitancy and fatigue regarding vaccines among patients, according to...
0
1
7
Second edition of Rheumatology Made Ridiculously Simple is out now! This edition we actually have a professional artist and are no longer relying on my own bad drawings! #meded #rheumatology
30
198
2K
Case Record of the MGH (@MassGeneralNews): A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and hilar lymphadenopathy, as well as an 8-mm nodule in the right lower lobe. A diagnosis was made. Read the full case
0
8
31
Our take on the strengths and weakness of the IOM criteria through the lens of autoimmunity @VirusesImmunity @MVGutierrezMD @MichaelPelusoMD @EBRheum @alhkim @jeffsparks @zach_wallace_md @CCalabreseDO @HealioRheum @RheumNow @DrPujaMehta1 @JYazdanyMD
https://t.co/S8y1yYbpj1
1
4
5
NEW—Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study https://t.co/n18GXUqw2m
0
15
38
Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: Baseline results of SAIL-RA https://t.co/zQQ6sFZGMT
#medRxiv
medrxiv.org
Background Risk factors and screening strategies for rheumatoid arthritis-associated interstitial lung disease (RA-ILD) have received limited evaluation in patients with early RA. We investigated...
0
1
2
Case-control study using VA data found increased fire smoke PM2.5 was associated with rheumatoid arthritis-associated interstitial lung disease, while NOx, ozone, and PM10 were associated with rheumatoid arthritis risk In A&R https://t.co/YO3kXlFGBQ
0
6
6
Tumour necrosis factor inhibitor safety in rheumatoid arthritis-associated interstitial lung disease Linked Comment by Gregory C McDermott & @jeffsparks
https://t.co/soKFvAFRpi
0
3
7
‘Chasing variants’ may not be the optimal COVID-19 vaccination strategy https://t.co/sSP9Ioi1iV Highly rational discussion on the influx of boosters by. @CCalabreseDO and Kevin Winthrop - must read for rheumatologists. - @alhkim @jeffsparks @BharatKumarMD @EBRheum @adamcifu
healio.com
Last autumn, the availability of the 2023-2024 updated COVID-19 vaccines, which more closely targeted the then-dominant XBB omicron subvariant lineage, promised to restore protections that had waned...
1
6
15
Happy holidays everyone! We are late this year but here is the link to the 5th international symposium on ILDs in rheumatic diseases. Registration is open and free. January 17-19th 1400 CET. Click on https://t.co/nyhIw9jJEO
@Worldsclerofnd @TobyMMaher @OrphaLung @PhilippeDieude
4
18
71
Thrilled to see the ACR/CHEST ILD 🫁 Guidelines were in the top 10 widely viewed articles in A&R and AC&R in 2024! Thank you to everyone who worked on the paper! @AshimaMakol @jeffsparks @ShervinAssassi @DidemSayginMD @NamrataRheum @ZsuzsMcMahanMD @SchroederInst
We're counting down the top 10 widely viewed articles published in ACR journals in 2024 To start, we highlight the 2023 ACR/CHEST ILD guidelines in people with systemic autoimmune rheumatic disease Screening/Monitoring: https://t.co/t5nU7wnMYZ Treatment: https://t.co/nReB53Cwsz
0
5
19
Incredibly grateful to collaborate on this @PCORI #VOICE trial with #pain #pragmatic trial leaders #ErinKrebs #WillBecker #Karen Seal. I was lucky to lead a team of incredibly talented PCPs, clinical psychologists and PharmDs. @VANorthTexas @UTSWInternalMed @JAMAInternalMed
Both an integrated pain team and pharmacist collaborative management resulted in similar small improvements in pain and substantial reductions in opioid dosage among chronic pain patients on long-term opioid therapy. https://t.co/ujOc5IBtqW
1
6
18
Bluesky now tracked as Altmetric research attention source - Research Information
researchinformation.info
Altmetric tracks Bluesky attention in real-time, detecting posts, reposts and quotes that contain a direct link to a scholarly output.
0
3
4
The road from post COVID autoAbs and IMIDS is not linear more clinical curation needed @jeffsparks @kim
@EBR @MaxKonigMD @MichaelPelusoMD @EricTopol @MVGutierrezMD Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
healio.com
WASHINGTON — The correlation between autoantibodies and new-onset autoimmune disease in individuals with long COVID symptoms remains “controversial,” according to a speaker at ACR Convergence 2024....
3
4
15
Hot off the press in @ARD_BMJ: new gene-respiratory disease endotypes that may drive #rheumatoidarthritis. This includes top genes to test in people with #ild for RA risk. Special thanks to mentors @jeffsparks @JohnDavisIII. Check it out here! https://t.co/Lmjw53Ikdm
0
4
9
🚨 #ACR24 data: Among patients with systemic autoimmune rheumatic diseases, circulating IL-18 levels were lower in those with long #COVID 📉 More from investigator @jeffsparks @BrighamWomens ⬇️ https://t.co/5zJxlCPWFC
healio.com
WASHINGTON — Among patients with systemic autoimmune rheumatic diseases, circulating interleukin-18 levels were lower in those with long COVID vs. those without, according to data presented at ACR...
0
1
5
#ACR24 Thanks to @TheLancetRheum for the warm reception. It was great to see everyone @ProftDr @Dr_AndreRibeiro @jeffsparks @SattuiSEMD @EBRheum #ElizabethVolkmann
0
6
30